The EKG in the patient treated with tricyclic antidepressants: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
|||
Line 4: | Line 4: | ||
'''Associate Editor-In-Chief:''' {{CZ}} | '''Associate Editor-In-Chief:''' {{CZ}} | ||
==Electrocardiographic Findings== | ==Electrocardiographic Findings== | ||
Line 26: | Line 26: | ||
{{Electrocardiography}} | {{Electrocardiography}} | ||
[[Category:Electrophysiology]] | [[Category:Electrophysiology]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] |
Revision as of 16:46, 20 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Electrocardiographic Findings
- EKG changes are observed in 20% of patients who are at therapeutic doses
- Prolongation of the QTc, displacement of the ST segment, T wave abnormalities, QRS widening, supraventricular and ventricular tachycardias can all occur.
- In overdose, widening of the QRS is frequent, and there is also QTc prolongation
Examples
![](/images/d/d8/ECG_nortr_intox.png)
![](/images/7/78/ECG_TCA_intox.jpg)
Image courtesy of ECGpedia.
![](/images/9/96/ECG_amitr_OD_during.jpg)
Image courtesy of ECGpedia.
![](/images/5/54/ECG_amitr_OD_before.jpg)
Image courtesy of ECGpedia.